| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/26/2012 | US20120021001 Marked bovine viral diarrhea virus vaccines |
| 01/26/2012 | US20120020995 Parapoxvirus vectors |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020987 MHC-Less cells |
| 01/26/2012 | US20120020984 Genetic Markers for Predicting Responsiveness to Combination Therapy |
| 01/26/2012 | US20120020977 Pancreatic cancer genes |
| 01/26/2012 | US20120020964 Antibodies for Norovirus |
| 01/26/2012 | US20120020957 Dengue virus neutralizing antibodies and use thereof |
| 01/26/2012 | US20120020955 Detection of Neurological Disorders With Immune Reactions |
| 01/26/2012 | US20120020954 Methods of predicting clinical course and treating multiple sclerosis |
| 01/26/2012 | US20120020953 Diagnosis and treatment of cancer |
| 01/26/2012 | US20120020949 MHC-LESS cells |
| 01/26/2012 | US20120020941 Use of blood group status iii |
| 01/26/2012 | US20120020929 Methods and compositions relating to neuronal cell and tissue differentiation |
| 01/26/2012 | US20120020925 Therapeutic Use of Specialized Endothelial Progenitor Cells |
| 01/26/2012 | US20120020905 Human sample matching system |
| 01/26/2012 | US20120020891 Metabolites for oral health and uses thereof |
| 01/26/2012 | US20120020888 Biomarker |
| 01/26/2012 | US20120020885 MHC-Less cells |
| 01/26/2012 | US20120018313 Novel biotracers and uses thereof for controlling filtration plants |
| 01/26/2012 | DE102010043541B4 Verfahren und Mittel zur Vorhersage der Überlebensdauer beim Pankreaskarzinom durch Analyse von Biomarkern Methods and means for predicting survival in pancreatic cancer by analysis of biomarkers |
| 01/26/2012 | DE102010032203A1 Verfahren und Vorrichtung zur passiven Trennung und Sortierung von Tropfen, insbesondere in einem mikrofluidischen System, durch Verwendung von nicht-optischen Markern für Reaktionen innerhalb der Tropfen Method and apparatus for passive separation and sorting of drops, particularly in a microfluidic system, by use of non-optical markers for reactions within the drop |
| 01/26/2012 | DE102009013748B4 Bestimmung von Interaktionen konstanter Antikörperteile mit Fc-gamma Rezeptoren Determination of interactions constant antibody portions with Fc-gamma receptors |
| 01/26/2012 | DE102007056198B4 Beurteilung der Wirkung eines endogenen oder exogenen Einflusses auf Epithelgewebe durch Kartierung des Gewebes mittels markierter histologischer Gewebeschnitte Evaluation of the effect of an endogenous or exogenous influence on epithelial tissue by mapping the tissue by means of labeled histological tissue sections |
| 01/26/2012 | DE102007031574B4 Minor-Spleißosom Testsystem zur Modulierung der Zellteilung Minor spliceosome test system for modulating cell division |
| 01/26/2012 | CA2842294A1 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 01/26/2012 | CA2813219A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia |
| 01/26/2012 | CA2811150A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | CA2809111A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | CA2809045A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 01/26/2012 | CA2806632A1 Methods and systems for analysis of single cells |
| 01/26/2012 | CA2806310A1 Methods of detecting diseases or conditions using phagocytic cells |
| 01/26/2012 | CA2806307A1 A kit for detection of donkey meat in meat products |
| 01/26/2012 | CA2806304A1 Methods of detecting prenatal or pregnancy-related diseases or conditions |
| 01/26/2012 | CA2806302A1 Methods of detecting neurological or neuropsychiatric diseases or conditions |
| 01/26/2012 | CA2806301A1 Methods of detecting cardiovascular diseases or conditions |
| 01/26/2012 | CA2806296A1 Methods of detecting kidney-associated diseases or conditions |
| 01/26/2012 | CA2806293A1 Methods of detecting autoimmune or immune-related diseases or conditions |
| 01/26/2012 | CA2806291A1 Methods for detecting signatures of disease or conditions in bodily fluids |
| 01/26/2012 | CA2806250A1 Cross-protective pathogen protection, methods and compositions thereof |
| 01/26/2012 | CA2806127A1 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 01/26/2012 | CA2806059A1 Method for reducing cost of enzymes in biorefinery |
| 01/26/2012 | CA2805915A1 Multiple input biologic classifier circuits for cells |
| 01/26/2012 | CA2805486A1 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
| 01/26/2012 | CA2805166A1 Method for monitoring a sterilization process |
| 01/26/2012 | CA2805076A1 Detector arrangement for blood culture bottles with colorimetric sensors |
| 01/26/2012 | CA2802111A1 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 01/25/2012 | EP2410064A1 High throughput methods comprising analysis of repetitive element DNA methylation |
| 01/25/2012 | EP2410063A1 Method, kit and device for detecting nucleic acid |
| 01/25/2012 | EP2410062A1 Selectivity profiling of PI3K interacting molecules against multiple targets |
| 01/25/2012 | EP2410052A1 In vitro method for the detecton of candida glabrata, diagnostic kit and use thereof |
| 01/25/2012 | EP2410050A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody |
| 01/25/2012 | EP2410049A1 RNA detection enzymes |
| 01/25/2012 | EP2410045A1 A method for testing an immune response |
| 01/25/2012 | EP2409980A1 3'modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
| 01/25/2012 | EP2409767A1 Modular cartridge, system and method for automated medical diagnosis |
| 01/25/2012 | EP2409156A2 Akt tyrosine 176 phosphorylation cancer biomarker |
| 01/25/2012 | EP2408936A2 Use of thermostable endonucleases for generating reporter molecules |
| 01/25/2012 | EP2408935A2 Abscription based molecular detection |
| 01/25/2012 | EP2408934A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof |
| 01/25/2012 | EP2408933A2 Improved detection of gene expression |
| 01/25/2012 | EP2408932A1 Msh2 and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer |
| 01/25/2012 | EP2408931A2 Test element for determining a body fluid and measurement method |
| 01/25/2012 | EP2408930A2 Biotinidase assay |
| 01/25/2012 | EP2408929A1 Process and apparatus for testing substances for potential carcinogenicity |
| 01/25/2012 | EP2408928A1 Method for detection of an enzyme-substrate reaction |
| 01/25/2012 | EP2408927A1 Probe compound for detecting and isolating enzymes and means and methods using the same |
| 01/25/2012 | EP2408920A2 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/25/2012 | EP2408919A2 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/25/2012 | EP2408914A1 Method for determining the sensitivity or resistance of retrovirus isolates to molecules, therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 01/25/2012 | EP2408906A1 Methods for modulating metabolic and circadian rhythms |
| 01/25/2012 | EP2408905A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 01/25/2012 | EP2408863A2 Nucleic acid binding dyes and uses therefor |
| 01/25/2012 | EP2408471A1 Targets for growth factor signalling and methods of therapy |
| 01/25/2012 | EP2281046B1 LUCIFERASE BIOSENSORS FOR cAMP |
| 01/25/2012 | EP2076606B1 2'-terminator related pyrophosphorolysis activated polymerization |
| 01/25/2012 | EP2034017B1 Gene involved in immortalization of human cancer cell and use thereof |
| 01/25/2012 | EP2016189B1 Droplet-based pyrosequencing |
| 01/25/2012 | EP1993672B1 Use of cardiotonic steroids as Na/K-ATPase ligands for the treatment of the skin |
| 01/25/2012 | EP1836314B1 Modified human growth hormone |
| 01/25/2012 | EP1759017B1 Dna sequences for the detection of and differentiation amongst pathogenic e.coli strains |
| 01/25/2012 | EP1735459B1 Methods for quantification of micrornas and small interfering rnas |
| 01/25/2012 | EP1633893B1 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample |
| 01/25/2012 | EP1613735B1 Expanding the eukaryotic genetic code |
| 01/25/2012 | EP1550462B1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 01/25/2012 | EP1440157B1 Methods and means for producing proteins with predetermined post-translational modifications |
| 01/25/2012 | EP1432991B1 Identification and isolation of somatic stem cells and uses thereof |
| 01/25/2012 | EP1426757B9 Method, tool and device for measuring concentration |
| 01/25/2012 | EP1336839B1 Biosensor |
| 01/25/2012 | EP1317547B1 Isolation and sequencing of the pknb gene of c. glutamicum |
| 01/25/2012 | EP1218545B1 Methods for preparing oligonucleotide solutions |
| 01/25/2012 | EP1192253B1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 01/25/2012 | CN202124628U Tissue chip sampling instrument |
| 01/25/2012 | CN102333892A A genetic marker for detection of human papillomavirus |
| 01/25/2012 | CN102333891A Single cell gene expression for diagnosis, prognosis and identification of drug targets |
| 01/25/2012 | CN102333890A Genomic selection and sequencing using encoded microcarriers |
| 01/25/2012 | CN102333889A A drug identification protocol for type 2 diabetes based on gene expression signatures |
| 01/25/2012 | CN102333888A Gene expression signature for classification of tissue of origin of tumor samples |
| 01/25/2012 | CN102333887A Method for detecting metastasis of gi cancer |
| 01/25/2012 | CN102333886A Solution phase homogeneous assays |